It is not easy to be in London and New York on the same day, but this Thursday Queen Letizia appears in both cities. Physically in the British capital and telematically in the city of skyscrapers with the same objective of shifting the focus from the person to research against cancer and, also, against the so-called rare diseases. The Queen has a priority commitment both to the fight against cancer and to patients affected by minority pathologies and her efforts to ensure that investment is made in research.
The Queen has traveled to London to attend the central event of the “World Cancer Research Day”, in which the Spanish Association Against Cancer (AECC), of which she is honorary president, promotes a global movement for cancer research. cancer in order to accelerate advances in cancer research and increase society's knowledge about the value and impact of research efforts, establishing September 24 as “World Cancer Research Day.”
For her appearance in London, a city where she was also last May for the coronation of Charles III, the Queen chose a blue chiffon midi dress with a print of red and pink flowers, from the brand Giorgio Armani, Round neck, long sleeves, marked waist and pleated skirt.
For this afternoon, the telematic intervention is planned at the event on rare diseases, parallel to the United Nations General Assembly, which is being held in New York, to promote a resolution of the World Health Organization in 2024 in favor of coverage universal health care for people with rare diseases.
The event aims to achieve the implementation of a single medical coverage to study how this is reflected in different countries specifically in rare diseases, as well as explore new methods to reduce the economic impact of these pathologies on people with rare diseases and your families.
For her part, Queen Sofía chairs, in Malaga, the Third International Congress on Research and Innovation in Neurodegenerative Diseases (CiiiEN) coinciding with International Alzheimer's Day.
Since 2013, the Reina Sofía Foundation, in collaboration with the CiiiEN Foundation and other entities, which this time has been joined by the Spanish Society of Neurology, have been organizing these meetings. Each year, this scientific conference aims to bring society closer to advances in research related to Alzheimer's and other neurodegenerative diseases. In addition, it seeks to highlight the evident need to advance in the search for solutions and answers at a global level due to the social implications that these diseases entail.
